Goldstein Advisors »

Halozyme Therapeutics shares owned by Goldstein Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Goldstein Advisors from 13F filings

Historical chart of Goldstein Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Goldstein Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Goldstein Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 24k 86.14
2023-09-30 $20k 24k 0.84
2023-06-30 $20k 24k 0.83

More positions owned by Goldstein Advisors

Ishares Tr Core S&p Ttl Stk (ITOT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Victory Portfolios Ii Core Intermediat (UITB)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Pimco Etf Tr Active Bd Etf (BOND)
J P Morgan Exchange Traded F Diversfed Rtrn (JPME)
J P Morgan Exchange Traded F Equity Premium (JEPI)
American Centy Etf Tr Diversified Mu (TAXF)
J P Morgan Exchange Traded F Active Growth (JGRO)
Hartford Fds Exchange Traded Mun Oportunite (HMOP)
Franklin Templeton Etf Tr Intl Cor Div Til (DIVI)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Core Msci Total (IXUS)

View all positions for Goldstein Advisors

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics